Hidradenitis Suppurativa - Topical, Intralesional, and Systemic Medical Management

Publication Date: July 1, 2019
Last Updated: March 14, 2022

Recommendations

Topical and Intralesional Therapies

Topical clindamycin may reduce pustules in HS, but it carries a high risk of bacterial resistance. (C, )
(II, III)
342465
Resorcinol 15% cream is recommended but may induce contact dermatitis. (C, III)
342465
Washing with chlorhexidine, zinc pyrithione, or other antibacterial washes is supported by expert opinion. (C, III)
(Chlorhexidine - Expert opinion)
342465
Intralesional corticosteroid for inflamed lesions is recommended on the basis of weak evidence for short-term control of HS flares. (C, III)
342465

Overview

Title

Hidradenitis Suppurativa - Topical, Intralesional, and Systemic Medical Management

Authoring Organization

Hidradenitis Suppurativa Foundation